Sign in
CompletedNo phase

Early Detection of PDAC in Patients With Chronic Pancreatitis

Key facts

Who runs it
First Affiliated Hospital Xi'an Jiaotong University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
359 people enrolled
Started
1 Aug 2024
Ended
1 Dec 2024
Type of study
Observational
Treatments tested
  • histopathological confirmation
Record updated
5 August 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • a confirmed diagnosis of chronic pancreatitis; (2) availability of pathological confirmation

Who cannot take part

  • age less than 18 years; (2) ambiguous pathology, including cases with only cytological findings or indications of pancreatic tissue alone; (3) preoperative diagnosis of PDAC or other pancreatic tumors before invasive procedure; (4) presence of tumors in other organs; (5) patients with missing data exceeding 15% of the total dataset

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this study is to find simple warning signs that doctors can use to spot pancreatic cancer early in people who have chronic pancreatitis.

Treatments tested

  • histopathological confirmation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
High Efficiency of Early Detection of Synchronous Pancreatic Ductal Adenocarcinoma in Patients With Chronic Pancreatitis
Record updated
5 August 2025